Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Spread of multidrug resistance among Ureaplasma serovars, Tunisia

View through CrossRef
Abstract Background Ureaplasma spp. have been implicated in a variety of clinical conditions and certain serovars are likely to be disease-associated. Hence, the ascending trend of Ureaplasma spp. resistance to antimicrobials should deserve more attention. Here we assessed the extent of antimicrobial resistance of Ureaplasma serovars in Tunisia, and investigated the underlying molecular basis. Methods This study included 101 molecularly typed Ureaplasma spp. clinical strains isolated over a 12-year time period (2005–2017). The antimicrobial susceptibility was tested against nine antibacterial agents using the broth microdilution method. Neighbor-joining tree was constructed to establish the phylogenetic relationships among isolates. Results We found that all ureaplasma isolates were resistant to ciprofloxacin and erythromycin, intermediately resistant to azithromycin, and susceptible to doxycycline, moxifloxacin and josamycin. Ofloxacin and levofloxacin resistance was found in 73.27 and 17.82%, respectively, while 37.62% of isolates proved resistant to tetracycline. Consequently, we detected an elevated multidrug resistance rate among ureaplasma isolates (37.62%), particularly among serovars 2, 5, 8, and 9 (77.77% overall), as well as serovars 4, 10, 12, and 13 (52.63% overall). In most cases, drug resistance was found to be associated with known molecular mechanisms, yet we have identified two novel mutations in the L22 protein, which might be associated with macrolide-resistance. Conclusion To our knowledge, this is the first study that reports the widespread expansion of multidrug resistance among Ureaplasma serovars, a finding of importance in terms of both surveillance and antimicrobial usage.
Title: Spread of multidrug resistance among Ureaplasma serovars, Tunisia
Description:
Abstract Background Ureaplasma spp.
have been implicated in a variety of clinical conditions and certain serovars are likely to be disease-associated.
Hence, the ascending trend of Ureaplasma spp.
resistance to antimicrobials should deserve more attention.
Here we assessed the extent of antimicrobial resistance of Ureaplasma serovars in Tunisia, and investigated the underlying molecular basis.
Methods This study included 101 molecularly typed Ureaplasma spp.
clinical strains isolated over a 12-year time period (2005–2017).
The antimicrobial susceptibility was tested against nine antibacterial agents using the broth microdilution method.
Neighbor-joining tree was constructed to establish the phylogenetic relationships among isolates.
Results We found that all ureaplasma isolates were resistant to ciprofloxacin and erythromycin, intermediately resistant to azithromycin, and susceptible to doxycycline, moxifloxacin and josamycin.
Ofloxacin and levofloxacin resistance was found in 73.
27 and 17.
82%, respectively, while 37.
62% of isolates proved resistant to tetracycline.
Consequently, we detected an elevated multidrug resistance rate among ureaplasma isolates (37.
62%), particularly among serovars 2, 5, 8, and 9 (77.
77% overall), as well as serovars 4, 10, 12, and 13 (52.
63% overall).
In most cases, drug resistance was found to be associated with known molecular mechanisms, yet we have identified two novel mutations in the L22 protein, which might be associated with macrolide-resistance.
Conclusion To our knowledge, this is the first study that reports the widespread expansion of multidrug resistance among Ureaplasma serovars, a finding of importance in terms of both surveillance and antimicrobial usage.

Related Results

Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Abstract Introduction: Hydatidosis, a zoonotic disease caused by the larval stage of Echinococcus granulosus, is a significant public health concern with notable economic impact. I...
Epidemiology of streptomycin resistant Salmonella from humans and animals in Ethiopia: A systematic review and meta-analysis
Epidemiology of streptomycin resistant Salmonella from humans and animals in Ethiopia: A systematic review and meta-analysis
Background Streptomycin is used as an epidemiological marker in monitoring programs for antimicrobial resistance in Salmonella serovars and indicates the presence of pentaresistanc...
Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients
Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients
AbstractInfection of humans with Chlamydia trachomatis, a bacterial pathogen with a unique intracellular replication cycle, may cause a variety of clinical manifestations. These ar...
Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019
Salmonella enterica serovars associated with bacteremia in Canada, 2006–2019
Background: Members of the bacterial genus Salmonella cause salmonellosis, a disease with a spectrum of clinical presentations from a self-limiting gastroenteritis to more severe b...
(620) Clinical Case Report: Isolation of Ureaplasma Urealyticum in Anal Exsudate
(620) Clinical Case Report: Isolation of Ureaplasma Urealyticum in Anal Exsudate
Abstract Introduction Ureaplasma urealyticum is a commensal microorganism of the human genitourinary tract. However, unde...
Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis
Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis
Lefamulin is the first of the pleuromutilin class of antimicrobials to be available for therapeutic use in humans. Minimum inhibitory concentrations of lefamulin were determined by...
Differentiation of Selected Salmonella Enterica Serovars by Fourier Transform Mid-Infrared Spectroscopy
Differentiation of Selected Salmonella Enterica Serovars by Fourier Transform Mid-Infrared Spectroscopy
Salmonella enterica serovars include pathogens responsible for high numbers of foodborne salmonellosis. Fourier transform infrared (FT-IR) spectroscopy can be used to rapidly and a...

Back to Top